Methadone Dose, Take Home Status, and Hospital Admission Among Methadone Maintenance Patients
Authors:
- Alexander Y. Md WalleyAWAlexander Y. Md Walley
- Debbie M. ScD ChengDCDebbie M. ScD Cheng
- Courtney E. PierceCPCourtney E. Pierce
- Clara Mhs ChenCCClara Mhs Chen
- Tiffany FilippellTFTiffany Filippell
- Jeffrey H. Md SametJSJeffrey H. Md Samet
- Daniel P. AlfordDADaniel P. Alford
- 1 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 6 (3) , 186-190
Abstract
Objectives: Among patients receiving methadone maintenance treatment (MMT) for opioid dependence, receipt of unobserved dosing privileges (take homes) and adequate doses (ie, ≥ 80 mg) are each associated with improved addiction treatment outcomes, but the association with acute care hospitalization is unknown. We studied whether take-home dosing and adequate doses (ie, ≥80 mg) were associated with decreased hospital admission among patients in an MMT. Methods: We reviewed daily electronic medical records of patients enrolled in one MMT program to determine receipt of take-home doses, methadone dose 80 mg or more, and hospital admission date. Nonlinear mixed-effects logistic regression models were used to evaluate whether take-home doses or dose 80 mg or more on a given day were associated with hospital admission on the subsequent day. Covariates in adjusted models included age, sex, race/ethnicity, human immunodeficiency virus status, medical illness, mental illness, and polysubstance use at program admission. Results: Subjects (n = 138) had the following characteristics: mean age 43 years; 52% female; 17% human immunodeficiency virus–infected; 32% medical illness; 40% mental illness; and 52% polysubstance use. During a mean follow-up of 20 months, 42 patients (30%) accounted for 80 hospitalizations. Receipt of take homes was associated with significantly lower odds of a hospital admission (adjusted odds ratio [AOR] = 0.26; 95% confidence interval [CI], 0.11–0.62), whereas methadone dose 80 mg or more was not (AOR = 1.01; 95% CI, 0.56–1.83). Conclusions: Among MMT patients, receipt of take homes, but not dose of methadone, was associated with decreased hospital admission. Take-home status may reflect not only patients' improved addiction outcomes but also reduced health care utilization.Keywords
This publication has 19 references indexed in Scilit:
- Earning “Take-Home” Privileges and Long-Term Outcome in a Methadone Maintenance Treatment ProgramJournal of Addiction Medicine, 2011
- 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel☆Drug and Alcohol Dependence, 2010
- Dosage Patterns in Methadone Treatment: Results from a National Survey, 1988–2005Health Services Research, 2008
- On-site medical care in methadone maintenance: Associations with health care use and expendituresJournal of Substance Abuse Treatment, 2007
- Do Mechanisms that Link Addiction Treatment Patients to Primary Care Influence Subsequent Utilization of Emergency and Hospital Care?Medical Care, 2006
- Pharmacokinetics of MethadoneJournal of Pain & Palliative Care Pharmacotherapy, 2005
- Methadone maintenance at different dosages for opioid dependenceCochrane Database of Systematic Reviews, 2003
- Utilization and Cost Impact of Integrating Substance Abuse Treatment and Primary CareMedical Care, 2003
- Effective Medical Treatment of Opiate AddictionJAMA, 1998
- Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patientsDrug and Alcohol Dependence, 1994